Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Dawson, Sarah"'
Autor:
Kuo, Joe Chin-Hun, Ibrahim, Ashraf EK, Dawson, Sarah, Parashar, Deepak, Howat, William J, Guttula, Kiran, Miller, Richard, Fearnhead, Nicola S, Winton, Douglas J, Neves, André A, Brindle, Kevin M
Publikováno v:
Scientific Reports
Colorectal cancer screening using conventional colonoscopy lacks molecular information and can miss dysplastic lesions. We tested here the ability of fluorescently labelled lectins to distinguish dysplasia from normal tissue when sprayed on to the lu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::de9b4ec2280b7bf2d31ca26072718f9d
http://wrap.warwick.ac.uk/79301/1/WRAP_srep24231.pdf
http://wrap.warwick.ac.uk/79301/1/WRAP_srep24231.pdf
Autor:
Bell, Charles C, Fennell, Katie A, Chan, Yih-Chih, Rambow, Florian, Yeung, Miriam M, Vassiliadis, Dane, Lara, Luis, Yeh, Paul, Martelotto, Luciano G, Rogiers, Aljosja, Kremer, Brandon E, Barbash, Olena, Mohammad, Helai P, Johanson, Timothy M, Burr, Marian L, Dhar, Arindam, Karpinich, Natalie, Tian, Luyi, Tyler, Dean S, MacPherson, Laura, Shi, Junwei, Pinnawala, Nathan, Yew Fong, Chun, Papenfuss, Anthony T, Grimmond, Sean M, Dawson, Sarah-Jane, Allan, Rhys S, Kruger, Ryan G, Vakoc, Christopher R, Goode, David L, Naik, Shalin H, Gilan, Omer, Lam, Enid YN, Marine, Jean-Christophe, Prinjha, Rab K, Dawson, Mark A
Non-genetic drug resistance is increasingly recognised in various cancers. Molecular insights into this process are lacking and it is unknown whether stable non-genetic resistance can be overcome. Using single cell RNA-sequencing of paired drug naïv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::669f8884269e1d2de07b751fa8d013ca
Autor:
Arnold, Nadine D, Pickworth, Josephine A, West, Laura E, Dawson, Sarah, Carvalho, Joana A, Casbolt, Helen, Braithwaite, Adam T, Iremonger, James, Renshall, Lewis, Germaschewski, Volker, McCourt, Matthew, Bland-Ward, Philip, Kowash, Hager, Hameed, Abdul G, Rothman, Alexander MK, Frid, Maria G, Roger Thompson, AA, Evans, Holly R, Southwood, Mark, Morrell, Nicholas W, Crossman, David C, Whyte, Moira KB, Stenmark, Kurt R, Newman, Christopher M, Kiely, David G, Francis, Sheila E, Lawrie, Allan
Pulmonary arterial hypertension (PAH) is a rare but fatal disease. Current treatments increase life expectancy but have limited impact on the progressive pulmonary vascular remodelling that drives PAH. Osteoprotegerin (OPG) is increased within serum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6dced78ba90bc56a446bfb2a6024898
Autor:
Coles, Alasdair, Azzopardi, Laura, Kousin-Ezewu, Onajite, Mullay, Harpreet, Thompson, Sara, Jarvis, Lorna, Davies, Jessica, Howlett, Sarah, Rainbow, Daniel, Babar, Judith, Sadler, Timothy, Brown, William, Needham, Edward, May, Karen, Georgieva, Zoya, Handel, Adam, Maio, Stefano, Deadman, Mary, Rota, Ioanna, Hollander, Georg, Dawson, Sarah, Jayne, David, Seggewiss-Berhardt, Ruth, Douek, Daniel, Isaacs, John, Jones, Joanne
Background: The lymphocyte-depleting antibody alemtuzumab is a highly effective treatment of relapsing-remitting multiple sclerosis (RRMS); however 50% of patients develop novel autoimmunity post-treatment. Most at risk are individuals who reconstitu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::522f0d03529120d4d4d5f9794e364e54
Autor:
Burr, Marian L, Sparbier, Christina E, Chan, Kah Lok, Chan, Yih-Chih, Kersbergen, Ariena, Lam, Enid YN, Azidis-Yates, Elizabeth, Vassiliadis, Dane, Bell, Charles C, Gilan, Omer, Jackson, Susan, Tan, Lavinia, Wong, Stephen Q, Hollizeck, Sebastian, Michalak, Ewa M, Siddle, Hannah V, McCabe, Michael T, Prinjha, Rab K, Guerra, Glen R, Solomon, Benjamin J, Sandhu, Shahneen, Dawson, Sarah-Jane, Beavis, Paul A, Tothill, Richard W, Cullinane, Carleen, Lehner, Paul J, Sutherland, Kate D, Dawson, Mark A
Loss of MHC class I (MHC-I) antigen presentation in cancer cells can elicit immunotherapy resistance. A genome-wide CRISPR/Cas9 screen identified an evolutionarily conserved function of polycomb repressive complex 2 (PRC2) that mediates coordinated t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30886b81527ad08b519be2f704abc846
Autor:
Luciano G. Martelotto, Mark A. Dawson, Paul Yeh, Jean-Christophe Marine, David L Goode, Charles C. Bell, Christopher R. Vakoc, Brandon E. Kremer, Rab K. Prinjha, Sean M. Grimmond, Enid Y.N. Lam, Olena Barbash, Laura MacPherson, Helai P. Mohammad, Chun Yew Fong, Nathan Pinnawala, Timothy M. Johanson, Katie A Fennell, Aljosja Rogiers, Marian L. Burr, Sarah-Jane Dawson, Florian Rambow, Ryan G. Kruger, Shalin H. Naik, Yih-Chih Chan, Anthony T. Papenfuss, Dane Vassiliadis, Rhys S. Allan, Luis Lara, Junwei Shi, Omer Gilan, Arindam Dhar, Luyi Tian, Natalie Karpinich, Miriam M. Yeung, Dean Tyler
Publikováno v:
Nature Communications
Nature Communications, Vol 10, Iss 1, Pp 1-15 (2019)
Nature Communications, Vol 10, Iss 1, Pp 1-15 (2019)
Non-genetic drug resistance is increasingly recognised in various cancers. Molecular insights into this process are lacking and it is unknown whether stable non-genetic resistance can be overcome. Using single cell RNA-sequencing of paired drug naïv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bad888bb74f93a0f32b447e522aea13
https://lirias.kuleuven.be/handle/123456789/647939
https://lirias.kuleuven.be/handle/123456789/647939
Autor:
Laura Azzopardi, T J Sadler, Joanne L. Jones, Stefano Maio, Sara A. J. Thompson, Ioanna A. Rota, Daniel B. Rainbow, Georg A. Holländer, Jessica L. Davies, J Babar, Edward Needham, Harpreet Kaur Mullay, S Dawson, R Seggewiss-Bernhardt, Brown Jwl., Onajite Kousin-Ezewu, Sarah Howlett, John D. Isaacs, D C Douek, Mary E. Deadman, David Jayne, Zoya Georgieva, K. May, Adam E. Handel, Lorna B. Jarvis, Alasdair Coles
Publikováno v:
JCI Insight
BACKGROUND The lymphocyte-depleting antibody alemtuzumab is a highly effective treatment for relapsing-remitting multiple sclerosis (RRMS); however, 50% of patients develop novel autoimmunity after treatment. Most at risk are individuals who reconsti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6162262bf66c0e2304991787786a1d80
https://ora.ox.ac.uk/objects/uuid:5fe18699-f27b-47a1-91be-f24f76f1eccd
https://ora.ox.ac.uk/objects/uuid:5fe18699-f27b-47a1-91be-f24f76f1eccd